
Meet officialdom.

Now meet the truth!
By Dr. John Reizer
Many people mistakenly believe scientific consensus forms when independent researchers come to the same conclusion. However, in many fields, big companies actually buy and pay for this consensus.
This scenario is particularly relevant to the medical and pharmaceutical industries.

Research costs a lot of money. Because governments often cut funding, scientists must rely on private companies for grants. This creates a conflict of interest. When a pharmaceutical company pays for a study, they expect a result that helps their business. If a study shows that a drug product is harmful or ineffective, the pharma company may choose not to publish it. By only releasing the positive results, scientists and corporations create a fake consensus.
Career pressure also plays a role. Scientists need constant funding to keep their jobs and their labs open. If a researcher publishes a finding that hurts the profits of a major drug industry leader, they risk losing their funding. Other scientists may avoid the topic altogether or disagree with the finding to stay on the good side of the people who provide the money.
Finally, Big Pharma and Big Medicine industry leaders influence the institutions that oversee science. They donate large sums of money to major universities and place their own people on regulatory boards. This allows them to control who gets hired, who gets promoted, and which studies are considered “official.”
When a few powerful people control the money, they control the narrative. In these cases, scientific consensus is not a search for truth but a product of investment.
As usual, if you want to know the skinny on anything, follow the money! 💰
Watch the Target List movie!
Click on the poster to watch Target List for free!
A film with humor and an important message
Click on the image to visit my author site.


